←Back to Expert Scholars
Translational Medicine / 转化医学Rare Melanoma Subtypes
Michael Postow
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Chief, Melanoma Service
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Michael Postow has led trials of checkpoint inhibitors across rare melanoma subtypes including mucosal and acral melanoma, as well as trials of nivolumab plus ipilimumab. He chairs the melanoma service at Memorial Sloan Kettering.
Share:
🧪Research Fields 研究领域
mucosal melanoma
acral melanoma
checkpoint inhibitors
rare melanoma
immunotherapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Michael Postow 的研究动态
Follow Michael Postow's research updates
留下邮箱，当我们发布与 Michael Postow（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment